This page was first published on 21 November 2022 and was last amended on 16 December 2022. View details of the changes below. |
---|
Master of Medicine (Pharmaceutical and Medical Device Development) |
---|
Master of Science in Medicine (Pharmaceutical and Medical Device Development) |
Students must complete 48 credit points, including: |
(a) 12 credit points of compulsory units of study; and |
(b) 24 credit points of stream specific units of study; and |
(c) 12 credit points of stream specific or general elective units of study. |
Master of Medicine (Advanced) (Pharmaceutical and Medical Device Development) |
Master of Science in Medicine (Advanced) (Pharmaceutical and Medical Device Development) |
Students must complete 60 credit points, including: |
(a) 48 credit points of study as required for the Master of Medicine/Master of Science in Medicine |
(b) 12 credit points of project units of study. |
Graduate Diploma in Medicine (Pharmaceutical and Medical Device Development) |
Graduate Diploma in Science in Medicine (Pharmaceutical and Medical Device Development) |
Students must complete 36 credit points, including: |
(a) 6 credit points of compulsory units of study; and |
(b) 24 credit points of stream specific units of study; and |
(c) 6 credit points of stream specific or general elective units of study. |
Graduate Certificate in Medicine (Pharmaceutical and Medical Device Development) |
Graduate Certificate in Science in Medicine (Pharmaceutical and Medical Device Development) (admission suspended) |
Students must complete 24 credit points, including: |
(a) 24 credit points of stream specific units of study. |
Unit of study | Credit points | A: Assumed knowledge P: Prerequisites C: Corequisites N: Prohibition |
---|---|---|
Compulsory units - Graduate Diploma, Graduate Diploma in Science |
||
PHAR7816 Introduction to the therapeutics industry |
6 | |
Compulsory units - Master of Medicine, Master of Science in Medicine, Master of Medicine (Advanced) |
||
PHAR7816 Introduction to the therapeutics industry |
6 | |
PHAR7824 Pharmaceutical and medical device development |
6 | C 18 credit points of stream specific units of study N PCOL5104 |
Stream specific units |
||
CEPI5100 Introduction to Clinical Epidemiology |
6 | |
PHAR7817 Pharmaceuticals: development and regulation |
6 | N PCOL5101 |
PCOL5102 Modern Therapeutics and Medical Devices |
6 | |
PHAR7823 Medical devices: development and regulation |
6 | N PCOL5103 |
PCOL5105 Commercialising MedTech and Pharma |
6 | |
PHAR7815 Regulation of Complementary Medicines |
6 | A Students will be expected to have a relevant health care, health science or science related undergraduate qualification or experience working in this sector |
General elective units |
||
BETH5104 Bioethics, Law and Policy |
6 | |
BETH5209 Medicines Policy, Economics and Ethics |
6 | A A degree in science, medicine, pharmacy, nursing, allied health, philosophy/ethics, sociology/anthropology, history, law, communications, public policy, business, economics, commerce, organisation studies, or other relevant field, or by special permission |
BMSC5002 Advances in Disease Diagnosis and Treatment |
6 | |
BSTA5003 Health Indicators and Health Surveys (HIS) |
6 | C BSTA5100 or BSTA5001 |
CEPI5200 Quality and Safety in Health Care |
6 | |
CEPI5215 Writing and Reviewing Medical Papers |
6 | A Some basic knowledge of summary statistic is assumed P (PUBH5010 or CEPI5100 or BSTA5011) N CEPI5214 |
CEPI5312 Diagnostic and Screening Tests (1 and 2) |
6 | P (PUBH5010 or CEPI5100) and (PUBH5018 or FMHU5002) N PUBH5208 or CEPI5202 or CEPI5311 |
CEPI5315 Introduction to Systematic Reviews |
6 | C CEPI5100 or PUBH5010 or CLTR5001 N CEPI5203 or CEPI5102 or CEPI5314 |
CLTR5001 Introduction to Clinical Trials |
6 | |
CLTR5004 Advanced Trial Design |
6 | P CLTR5001 and CLTR5007 |
FMHU5002 Introductory Biostatistics |
6 | N PUBH5018 |
HPOL5001 Health Systems and Financing |
6 | N GLOH5135 |
HPOL5006 Business of Health |
6 | N SMBA6122 |
HPOL5012 Leadership in Health |
6 | A Students are expected to have at least 1 year work experience in a health practice, policy or administrative role |
Project units of study |
||
MEDF5301 Project (Advanced Masters) |
12 | |
MEDF5302 Project (Advanced Masters) (Part A) |
6 | |
MEDF5303 Project (Advanced Masters) (Part B) |
6 |
Date | Original publication | Post-publication amendment |
---|---|---|
07/12/2022 | Co-requisites (C) for PHAR7824 published as: C PHAR7816 and 18 credit points of stream specific units of study from (CEPI5100 or PCOL5101 or PHAR7817) and (PCOL5102 or PCOL5103 or PHAR7823) and (PCOL5105 or PHAR7815) |
Co-requisites (C) for PHAR7824 amended to: C PHAR7816 and 18 credit points of stream specific units of study from (CEPI5100 or (PCOL5101 or PHAR7817) or PCOL5102 or (PCOL5103 or PHAR7823) or PCOL5105 or PHAR7815) |
16/12/2022 | Co-requisites (C) for PHAR7824 was published post-publication as: C PHAR7816 and 18 credit points of stream specific units of study from (CEPI5100 or (PCOL5101 or PHAR7817) or PCOL5102 or (PCOL5103 or PHAR7823) or PCOL5105 or PHAR7815) |
Co-requisites (C) for PHAR7824 amended to: C 18 credit points of stream specific units of study |